Healthcare Industry News: HSMN NewsFeed
News Release - August 23, 2018
Astellas Promotes Rodrigo Fernandez to Vice President, Latin AmericaNORTHBROOK, Ill., Aug. 23, 2018 -- (Healthcare Sales & Marketing Network) -- Astellas today announced that Rodrigo Fernandez has been promoted to vice president, Latin America, based in Northbrook and reporting to Percival Barretto-Ko, president, Astellas Americas. Fernandez previously served as executive director of Astellas' International Business with responsibility for managing Astellas' business in Latin America outside of Brazil and Colombia.
In his new role, Fernandez will be responsible for leading Astellas' operations and continued growth across Latin America. Joćo Carlos Britto, general manager of Astellas Farma Brasil and Sandra Cifuentes, general manager of Astellas Farma Colombia will now report to Fernandez, along with the International Business team.
"Astellas is deeply committed to delivering and creating value through products that serve patients across nearly 20 countries in Latin America," said Barretto-Ko. "I'm confident that Rodrigo's deep experience, collaborative approach and track record at Astellas will position the company well as we build for the future."
A native of Costa Rica, Fernandez has more than 20 years of global pharmaceutical experience. Prior to Astellas, he led AstraZeneca's business as country president in Central America, the Caribbean, Ecuador and Peru. Since 2004, Fernandez also served in various roles of increasing responsibility at AstraZeneca, including country manager and marketing company president for Slovenia and the West Balkans and global and regional commercial lead roles for various therapeutic areas. Fernandez holds a degree in Pharmacy from the University of Costa Rica and various executive certifications.
Astellas is a pharmaceutical company dedicated to improving the health of people around the world through the provision of innovative and reliable pharmaceutical products. For more information on Astellas, please visit our website at http://www.astellas.us/. You can also follow us on Twitter at @AstellasUS, Facebook at http://www.facebook.com/AstellasUS or LinkedIn at www.linkedin.com/company/astellas-pharma.
Issuer of this News Release is solely responsible for its
Please address inquiries directly to the issuing company.
Related News ItemsSeattle Genetics and Astellas Announce Positive Topline Results from Pivotal Trial of Enfortumab Vedotin in Locally Advanced or Metastatic Urothelial Cancer
Astellas Announces Key Senior Leadership Promotions and New Hire in Medical and Development Organization
EVENITY(TM) (romosozumab) Receives Approval In Japan For The Treatment Of Osteoporosis In Patients At High Risk Of Fracture